These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30937268)

  • 1. Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy.
    Zhu Q; Ling X; Yang Y; Zhang J; Li Q; Niu X; Hu G; Chen B; Li H; Wang Y; Deng Z
    Adv Sci (Weinh); 2019 Mar; 6(6):1801899. PubMed ID: 30937268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison.
    Wu JY; Li YJ; Hu XB; Huang S; Luo S; Tang T; Xiang DX
    J Control Release; 2021 Aug; 336():510-521. PubMed ID: 34237399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
    Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
    Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
    [No Abstract]   [Full Text] [Related]  

  • 4. Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy.
    Huang X; Wu W; Jing D; Yang L; Guo H; Wang L; Zhang W; Pu F; Shao Z
    J Control Release; 2022 Mar; 343():107-117. PubMed ID: 35077741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-displaying-exosomes using RNA nanotechnology for targeted delivery of multi-specific drugs for liver cancer regression.
    Ellipilli S; Wang H; Binzel DW; Shu D; Guo P
    Nanomedicine; 2023 Jun; 50():102667. PubMed ID: 36948369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.
    Zhan Q; Yi K; Cui X; Li X; Yang S; Wang Q; Fang C; Tan Y; Li L; Xu C; Yuan X; Kang C
    Neuro Oncol; 2022 Nov; 24(11):1871-1883. PubMed ID: 35312010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cells-Derived Exosomes as Dexamethasone Delivery Vehicles for Autoimmune Hepatitis Therapy.
    Zhao J; Li Y; Jia R; Wang J; Shi M; Wang Y
    Front Bioeng Biotechnol; 2021; 9():650376. PubMed ID: 33859980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
    Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
    Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnetic targeting of paclitaxel-loaded poly(lactic-
    Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
    Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human embryonic stem cell-derived exosomes promote pressure ulcer healing in aged mice by rejuvenating senescent endothelial cells.
    Chen B; Sun Y; Zhang J; Zhu Q; Yang Y; Niu X; Deng Z; Li Q; Wang Y
    Stem Cell Res Ther; 2019 May; 10(1):142. PubMed ID: 31113469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell-derived exosome-entrapped paclitaxel can enhance its anti-tumor effect.
    Han D; Wang K; Zhang T; Gao GC; Xu H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5703-5713. PubMed ID: 32495906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
    Li C; Guan N; Liu F
    J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering exosomes derived from subcutaneous fat MSCs specially promote cartilage repair as miR-199a-3p delivery vehicles in Osteoarthritis.
    Zhao S; Xiu G; Wang J; Wen Y; Lu J; Wu B; Wang G; Yang D; Ling B; Du D; Xu J
    J Nanobiotechnology; 2023 Sep; 21(1):341. PubMed ID: 37736726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment.
    Zhang Z; Luo X; Xue X; Pang M; Wang X; Yu L; Qian J; Li X; Tian M; Lu A; Lu C; Liu Y
    Int J Nanomedicine; 2024; 19():743-758. PubMed ID: 38283199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood-Brain Barrier for Chemo-immunotherapy against Glioblastoma.
    Cui J; Wang X; Li J; Zhu A; Du Y; Zeng W; Guo Y; Di L; Wang R
    ACS Nano; 2023 Jan; ():. PubMed ID: 36626296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA engineered umbilical cord stem cell-derived exosomes direct tendon regeneration by mTOR signaling.
    Yao Z; Li J; Xiong H; Cui H; Ning J; Wang S; Ouyang X; Qian Y; Fan C
    J Nanobiotechnology; 2021 Jun; 19(1):169. PubMed ID: 34090456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer.
    Zheng W; Zhu T; Tang L; Li Z; Jiang G; Huang X
    J Transl Med; 2023 Jun; 21(1):383. PubMed ID: 37308954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration.
    Ju Y; Hu Y; Yang P; Xie X; Fang B
    Mater Today Bio; 2023 Feb; 18():100522. PubMed ID: 36593913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
    Liang L; Zhao L; Wang Y; Wang Y
    Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy.
    Wang Y; Huo Y; Zhao C; Liu H; Shao Y; Zhu C; An L; Chen X; Chen Z
    J Control Release; 2024 Apr; 368():170-183. PubMed ID: 38382811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.